Explore All 557 Venture Life Science Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | April 17, 2000 |
| Target | Nereus Pharmaceuticals |
| Sector | Life Science |
| Investor(s) | Alta Partners |
| Deal Type | Venture |
FILTER BY
| Category | Venture Capital Firm |
|---|---|
| Founded | 1996 |
| PE ASSETS | 2.6B USD |
| Size | Large |
| Type | Sector Focused |
Alta Partners is a venture capital firm that targets investments in early and later stage life science companies, including biopharmaceuticals, medical technology, and information technology businesses. Alta was formed as an early stage investor but has since expanded its investment range to provide later stage growth capital to private and young public companies. Alta was established in 1996 and is headquartered in San Francisco, California.
| Deal Context for Investor | # |
|---|---|
| Overall | 8 of 59 |
| Sector: Life Science | 7 of 50 |
| Type: Venture | 6 of 48 |
| State: California | 5 of 31 |
| Country: United States | 7 of 50 |
| Year: 2000 | 4 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2000-03-24 |
InterMune
Brisbane, California, United States InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. In pulmonology, the company is focused on therapies for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive, irreversible, unpredictable and ultimately fatal lung disease. InterMune's research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2000-08-01 |
LJL Biosystems
Sunnyvale, California, United States LJL Biosystems, Inc. is a provider of automated instrumentation systems for clinical, research and drug development applications. |
Sell | - |
